BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 6292689)

  • 1. Magnesium regulation of the beta-receptor-adenylate cyclase complex. II. Sc3+ as a Mg2 antagonist.
    Maguire ME
    Mol Pharmacol; 1982 Sep; 22(2):274-80. PubMed ID: 6292689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinctions in beta-adrenergic receptor interactions with the magnesium-guanine nucleotide coupling proteins in turkey erythrocyte and S49 lymphoma membranes.
    Vauquelin G; Cech SY; André C; Strosberg AD; Maguire ME
    J Cyclic Nucleotide Res; 1982; 8(3):149-62. PubMed ID: 6300206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Demonstration of beta-2 adrenergic receptors of high coupling efficiency in human neutrophil sonicates.
    Galant SP; Allred SJ
    J Lab Clin Med; 1980 Jul; 96(1):15-23. PubMed ID: 6248606
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple sites of action of ethanol on adenylate cyclase.
    Rabin RA; Molinoff PB
    J Pharmacol Exp Ther; 1983 Dec; 227(3):551-6. PubMed ID: 6606704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. II. Relationship between receptor number and response.
    Mahan LC; Insel PA
    Mol Pharmacol; 1986 Jan; 29(1):16-22. PubMed ID: 3003560
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hormonal inhibition of adenylate cyclase. A crucial role for Mg2+.
    Bockaert J; Cantau B; Sebben-Perez M
    Mol Pharmacol; 1984 Sep; 26(2):180-6. PubMed ID: 6541292
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dithiothreitol on the beta-adrenergic receptor of S49 wild type and cyc- lymphoma cells: decreased affinity of the ligand-receptor interaction.
    Clark RB; Green DA; Rashidbaigi A; Ruoho A
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(3):203-20. PubMed ID: 6321573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Muscarinic cholinergic receptor-mediated attenuation of adenylate cyclase activity in rat heart membranes.
    Smith MM; Harden TK
    J Cyclic Nucleotide Protein Phosphor Res; 1985; 10(2):197-210. PubMed ID: 3998232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Magnesium regulation of the beta-receptor-adenylate cyclase complex. I. Effects of manganese on receptor binding and cyclase activation.
    Cech SY; Maguire ME
    Mol Pharmacol; 1982 Sep; 22(2):267-73. PubMed ID: 6292688
    [No Abstract]   [Full Text] [Related]  

  • 10. Characterization of adenylate cyclase-coupled alpha 2-adrenergic receptors in rat renal cortex using [3H]yohimbine.
    Woodcock EA; Johnston CI
    Mol Pharmacol; 1982 Nov; 22(3):589-94. PubMed ID: 6296653
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of Mg2+ on the in vitro responsiveness of adenylate cyclase from hearts of aging rats.
    Pignatti C; Tantini B; Zanfanti ML; Sacchi P; Clo C
    Cardioscience; 1993 Jun; 4(2):105-9. PubMed ID: 8347790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epinephrine desensitization of adenylate cyclase from cyc- and S49 cultured lymphoma cells.
    Green DA; Friedman J; Clark RB
    J Cyclic Nucleotide Res; 1981; 7(3):161-72. PubMed ID: 7287968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BW373U86: a nonpeptidic delta-opioid agonist with novel receptor-G protein-mediated actions in rat brain membranes and neuroblastoma cells.
    Childers SR; Fleming LM; Selley DE; McNutt RW; Chang KJ
    Mol Pharmacol; 1993 Oct; 44(4):827-34. PubMed ID: 8232233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of receptor-mediated activation of GTP-binding protein/adenylate cyclase using the encounter coupling model.
    Stickle D; Barber R
    Mol Pharmacol; 1993 Mar; 43(3):397-411. PubMed ID: 8095693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-adrenergic receptor overexpression in the fetal rat: distribution, receptor subtypes, and coupling to adenylate cyclase activity via G-proteins.
    Slotkin TA; Lau C; Seidler FJ
    Toxicol Appl Pharmacol; 1994 Dec; 129(2):223-34. PubMed ID: 7992312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modification of G protein-coupled functions by low-pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins.
    Selley DE; Breivogel CS; Childers SR
    Mol Pharmacol; 1993 Oct; 44(4):731-41. PubMed ID: 8232223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ontogeny of regulatory mechanisms for beta-adrenoceptor control of rat cardiac adenylyl cyclase: targeting of G-proteins and the cyclase catalytic subunit.
    Zeiders JL; Seidler FJ; Slotkin TA
    J Mol Cell Cardiol; 1997 Feb; 29(2):603-15. PubMed ID: 9140819
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional uncoupling of muscarinic receptors from adenylate cyclase in rat cardiac membranes by the active component of islet-activating protein, pertussis toxin.
    Kurose H; Ui M
    J Cyclic Nucleotide Protein Phosphor Res; 1983; 9(4-5):305-18. PubMed ID: 6687224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the rabbit ventricular myocardial receptor for angiotensin II. Evidence for two sites of different affinities and specificities.
    Wright GB; Alexander RW; Ekstein LS; Gimbrone MA
    Mol Pharmacol; 1983 Sep; 24(2):213-21. PubMed ID: 6310363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Direct evidence for the role of the coupling proteins in forskolin activation of adenylate cyclase.
    Green DA; Clark RB
    J Cyclic Nucleotide Res; 1982; 8(5):337-46. PubMed ID: 6892111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.